Skip to content

Evaluation of reading vision after cataract surgery and lens implantation

Comparison of near vision performance of the Crystalens® HD against the Technis® Aspheric Intra-Ocular Lens: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN44390838
Enrollment
80
Registered
2009-10-26
Start date
2009-11-20
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts/near vision/intra-ocular lens Eye Diseases Other cataract

Interventions

Crystalens® HD vs standard monofocal IOL Participants and outcome assessors will be blinded to participant allocation.

Sponsors

Guy's and St Thomas' NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, aged 18 years or older 2. Documented diagnosis of bilateral cataract requiring surgery 3. Potential visual acuity of 6/12 or better in both eyes 4. Patients who require an IOL in the range of 10-30 dioptres 5. Corneal astigmatism less than/equal to 1.0 dioptres after cataract surgery 6. Patients willing and able to provide informed consent and able to attend follow-up appointments

Exclusion criteria

Exclusion criteria: 1. Any coexisting ocular disease 2. Treatment with any ocular medication apart from artificial tear drops 3. Patients who are not fluent in English 4. Females of childbearing potential who are currently pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frame
Visual acuity All primary and seconadry outcomes will be assessed at 1, 3, 6, 12 and 24 months.

Secondary

MeasureTime frame
1. Refraction 2. Objective optical image quality 3. Posterior capsule opacification 4. Measurement of IOL position 5. Contrast sensitivity 6. Objective and subjective measure of accommodation 7. Pupil size All primary and seconadry outcomes will be assessed at 1, 3, 6, 12 and 24 months.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026